Name: Inhibrx Biosciences, Inc. (INBX) Balance Sheet
Creator: FinSpry

Inhibrx Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Inhibrx Biosciences, Inc. (INBX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	152.60	277.92	0.00
Cash & Short-Term Investments	152.60	277.92	0.00
Accounts Receivable	0.42	0.78	0.24
Inventory	2.00	9.89	0.81
Other Current Assets	4.19	0.73	0.67
Total Current Assets	160.40	295.36	6.26
Non-Current Assets
Property, Plant & Equipment (Net)	13.54	9.37	7.22
Other Non-Current Assets	6.83	3.16	3.16
Total Non-Current Assets	20.37	12.54	10.38
Total Assets	180.77	307.89	16.65
Current Liabilities
Accounts Payable	14.89	10.95	4.34
Short-Term Debt	1.60	0.00	0.00
Accrued Liabilities	24.25	36.79	11.20
Other Current Liabilities	29.89	0.00	0.00
Total Current Liabilities	40.73	56.31	20.77
Non-Current Liabilities
Long-Term Debt	6.45	206.97	3.17
Other Non-Current Liabilities	0.00	0.00	0.00
Total Non-Current Liabilities	6.45	208.08	3.17
Total Liabilities	47.18	264.39	23.95
Stockholders' Equity
Common Stock	0.00	0.01	-7.30
Retained Earnings	-106.13	-613.73	0.00
Additional Paid-in Capital	239.72	657.23	0.00
Shares Outstanding	14.48	14.24	14.24
Total Stockholders' Equity	133.58	43.50	-7.30
Total Liabilities & Equity	180.77	307.89	16.65